Literature DB >> 9151848

Efficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidation.

M S McBride1, M D Schwartz, A T Panganiban.   

Abstract

To determine whether there is a cis-acting effect of translational expression of gag on RNA encapsidation, we compared the encapsidation of wild-type RNA with that of a mutant in which the translation of gag was ablated. This comparison indicated that there is not such a cis effect. To determine what is necessary and sufficient for encapsidation, we measured the relative encapsidation efficiencies of human immunodeficiency virus type 1 vector RNAs containing mutations in domains proximal to the canonical encapsidation signal or containing large deletions in the remainder of the genome. These data indicate that TAR and two additional regions are required for encapsidation and that the 5' end of the genome is sufficient for encapsidation. The Rev-responsive element is required mainly for efficient RNA transport from the nucleus to the cytoplasm. A foreign sequence was found to have a negative effect on encapsidation upon placement within the parental vector. Interestingly, this negative effect was compounded by multiple copies of the sequence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9151848      PMCID: PMC191676     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  5' regions of HIV-1 RNAs are not sufficient for encapsidation: implications for the HIV-1 packaging signal.

Authors:  R D Berkowitz; M L Hammarskjöld; C Helga-Maria; D Rekosh; S P Goff
Journal:  Virology       Date:  1995-10-01       Impact factor: 3.616

2.  Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His).

Authors:  J K Wakefield; S M Kang; C D Morrow
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

3.  trans-acting proteins involved in RNA encapsidation and viral assembly in human immunodeficiency virus type 1.

Authors:  J F Kaye; A M Lever
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

4.  Requirements for DNA strand transfer during reverse transcription in mutant HIV-1 virions.

Authors:  B Berkhout; J van Wamel; B Klaver
Journal:  J Mol Biol       Date:  1995-09-08       Impact factor: 5.469

5.  cis-acting sequences involved in human immunodeficiency virus type 1 RNA packaging.

Authors:  J F Kaye; J H Richardson; A M Lever
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

6.  An integration-defective U5 deletion mutant of human immunodeficiency virus type 1 reverts by eliminating additional long terminal repeat sequences.

Authors:  E Vicenzi; D S Dimitrov; A Engelman; T S Migone; D F Purcell; J Leonard; G Englund; M A Martin
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

7.  Mutational analysis of the bipartite dimer linkage structure of human immunodeficiency virus type 1 genomic RNA.

Authors:  J C Paillart; R Marquet; E Skripkin; B Ehresmann; C Ehresmann
Journal:  J Biol Chem       Date:  1994-11-04       Impact factor: 5.157

8.  Specific binding of human immunodeficiency virus type 1 (HIV-1) Gag-derived proteins to a 5' HIV-1 genomic RNA sequence.

Authors:  U Geigenmüller; M L Linial
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

9.  Concerted integration of retrovirus-like DNA by human immunodeficiency virus type 1 integrase.

Authors:  G Goodarzi; G J Im; K Brackmann; D Grandgenett
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  Amphibian transcription factor IIIA proteins contain a sequence element functionally equivalent to the nuclear export signal of human immunodeficiency virus type 1 Rev.

Authors:  R A Fridell; U Fischer; R Lührmann; B E Meyer; J L Meinkoth; M H Malim; B R Cullen
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

View more
  75 in total

1.  An Mpsi-containing heterologous RNA, but not env mRNA, is efficiently packaged into avian retroviral particles.

Authors:  J D Banks; B O Kealoha; M L Linial
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Duplication of the primary encapsidation and dimer linkage region of human immunodeficiency virus type 1 RNA results in the appearance of monomeric RNA in virions.

Authors:  J Sakuragi ; T Shioda; A T Panganiban
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Human immunodeficiency virus types 1 and 2 differ in the predominant mechanism used for selection of genomic RNA for encapsidation.

Authors:  J F Kaye; A M Lever
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

Review 4.  Destiny of unspliced retroviral RNA: ribosome and/or virion?

Authors:  Melinda Butsch; Kathleen Boris-Lawrie
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

5.  Translation is not required To generate virion precursor RNA in human immunodeficiency virus type 1-infected T cells.

Authors:  M Butsch; K Boris-Lawrie
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  Mutational interference mapping experiment (MIME) for studying RNA structure and function.

Authors:  Redmond P Smyth; Laurence Despons; Gong Huili; Serena Bernacchi; Marcel Hijnen; Johnson Mak; Fabrice Jossinet; Li Weixi; Jean-Christophe Paillart; Max von Kleist; Roland Marquet
Journal:  Nat Methods       Date:  2015-08-03       Impact factor: 28.547

7.  A heterologous, high-affinity RNA ligand for human immunodeficiency virus Gag protein has RNA packaging activity.

Authors:  J L Clever; R A Taplitz; M A Lochrie; B Polisky; T G Parslow
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

8.  High frequency of genetic recombination is a common feature of primate lentivirus replication.

Authors:  Jianbo Chen; Douglas Powell; Wei-Shau Hu
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

9.  Encapsidation determinants located downstream of the major splice donor in the maedi-visna virus leader region.

Authors:  Helga Bjarnadottir; Bjarki Gudmundsson; Janus Gudnason; Jon J Jonsson
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

10.  Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation.

Authors:  J F Kaye; A M Lever
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.